Expression of lncRNA LINC00943 in lung squamous cell carcinoma and its relationship with tumor progression
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Long noncoding RNA LINC00943 (lncRNA LINC00943) acts as a tumor suppressor in lung squamous cell carcinoma (LUSC). Overexpression of LINC00943 inhibits LUSC cell migration and invasion, suggesting its potential as a prognostic biomarker.
Area Of Science
- Oncology
- Molecular Biology
- Genetics
Background
- Long noncoding RNAs (lncRNAs) are implicated in various cancers.
- LINC00943 is a lncRNA with a known role in cancer development.
- Its specific role in lung squamous cell carcinoma (LUSC) requires further investigation.
Purpose Of The Study
- To investigate the prognostic role of LINC00943 in LUSC.
- To understand the impact of LINC00943 on LUSC development.
- To explore the molecular mechanism of LINC00943 in LUSC.
Main Methods
- Analysis of LINC00943 and miR-196b-5p expression in 89 LUSC patients.
- Correlation analysis between LINC00943 expression and clinical data.
- In vitro assays (Transwell migration and invasion) to assess LINC00943 function.
- Pearson correlation and luciferase assays to elucidate the LINC00943-miR-196b-5p interaction.
Main Results
- LINC00943 expression was significantly reduced in LUSC tissues compared to normal controls.
- miR-196b-5p expression was markedly increased in LUSC tissues.
- A negative correlation was observed between LINC00943 and miR-196b-5p.
- Overexpression of LINC00943 suppressed LUSC cell migration and invasion.
- LINC00943 demonstrated prognostic value in LUSC, targeting miR-196b-5p.
Conclusions
- LINC00943 functions as a molecular sponge for miR-196b-5p, regulating LUSC progression.
- LINC00943 overexpression inhibits LUSC cell deterioration.
- LINC00943 holds significant potential as a prognostic biomarker for LUSC.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...